Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shenhuang
- Development stage
- Unknown
- Lead developer
- Beijing Tcmages Pharmaceutical
- Administration
- Oral, Topical
01
Overview
Shenhuang is a traditional Chinese herbal medicine available in multiple formulations including granules, plaster, and powder. Each formulation contains similar herbal ingredients but is used in different applications. The main components typically include Panax ginseng, Rheum palmatum, and other herbs. It has been studied for treating COVID-19, reducing chemotherapy side effects, and treating inflammatory conditions.
- Other names
- Shenhuang GranuleShenhuang PlasterShenhuang PowderSHGSHP
02
Targets
IL8 (C-X-C Motif Chemokine Ligand 8)DNMT1 (DNA (cytosine-5)-methyltransferase 1)HDAC3 (Histone Deacetylase 3)HSP90AA1 (Heat shock protein HSP90-alpha)IFNG (Interferon gamma)MDM2 (Mouse double minute 2 homolog)MMP9 (Matrix metalloproteinase-9)NSP13 (SARS-CoV-2 helicase)
Beyond the preview
Go deeper on shenhuang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shenhuang.